H2C IN THE NEWS
H2C Article on Health Tech Startup Investment Is a Cover Article for The Governance Institute
ABOUT HAMMOND HANLON CAMP LLC
Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations and related companies throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers & acquisitions, capital markets, real estate, and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, go to h2c.com
Kelly T. Duong
Hammond Hanlon Camp LLC
623 Fifth Avenue
New York, NY 10022
3333 Piedmont Road
Atlanta, GA 30305
311 South Wacker Drive
Chicago, IL 60606
4655 Executive Drive
San Diego, CA 92121
Hammond Hanlon Camp LLC (“H2C”) is pleased to share that Bill Hanlon’s article for The Governance Institute, featuring key considerations for healthcare leaders in determining whether direct investment in health tech startups is the right move, is the cover article for the Institute's "System Focus" newsletter.
Direct private investment by large health systems in healthcare services and technology companies is gaining traction, fueled by new competitors and innovations that are rapidly changing traditional business models. Today, more than 40 health systems have launched direct private investment initiatives or are participating in funds created by others.
In his article, “Disruption through Innovation: How Health Systems Are Becoming a New Class of Private Investor,” Hanlon, H2C Principal and Co-founder, provides insight on this trend from his work with large health systems that have made direct investments in healthcare services and technology companies. Hanlon also shares three questions health system board members and leaders should ask in evaluating the business case for investment in a health tech startup.
Read the article online (subscribers-only access). Care to continue the conversation? Email Bill for more information.